SantulliG., 2013.Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts,J Cardiovasc Dis Res 1 1 -2
ArthamSM,LavieCJ,MilaniRV,PatelDA,VermaA,VenturaHO., 2009.Clinical impact of left ventricular hypertrophy and implications for regression,Prog Cardiovasc Dis 52 153 -67
LiebW,XanthakisV,SullivanLM,AragamJ,PencinaMJ,LarsonMG, 2009.Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham offspring study,Circulation 119 3085 -92
ChengS,FernandesVR,BluemkeDA,McClellandRL,KronmalRA,LimaJA, 2009.Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: The Multi-Ethnic Study of Atherosclerosis,Circ Cardiovasc Imaging 2 191 -8
PierdoenicoSD,CuccurulloF, 2010.Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis,Am J Hypertens 23 876 -81
DubeyTN,PaithankarU,YadavBS, 2016.Correlation of echocardiographic left ventricular mass index and electrocardiographic left ventricular hypertrophy variables,Int J Contemp Med Res 3 1287 -9
JainA,McClellandRL,PolakJF,SheaS,BurkeGL,BildDE, 2011.Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: the Multi-Ethnic Study of Atherosclerosis(MESA),Circ Cardiovasc Imaging 4 8 -15
GargS,de LemosJA,AyersC,KhouriMG,PandeyA,BerryJD, 2015.Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population,JACC Cardiovasc Imaging 8 1034 -41
AlexescuTG,CozmaA,Sitar-TautA,NegreanV,HandruMI,MotocuM, 2016.Cardiac Changes in Overweight and Obese Patients,Rom J Intern Med 54 161 -72
LorellBH,CarabelloBA,Prognosis, 2000.,Circulation 102 470 -9
KaoMP,AngDS,GandySJ,NadirMA,HoustonJG,LangCC, 2011.Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease,J Am Soc Nephrol 22 1382 -9
TakimotoE,KassDA, 2007.Role of oxidative stress in cardiac hypertrophy and remodelling,Hypertension 49 241 -8
KelleyEE,KhooNK,HundleyNJ,MalikUZ,FreemanBA,TarpeyMM, 2010.Hydrogen peroxide is the major oxidant product of xanthine oxidase,Free Radic Biol Med 48 493 -8
XuX,HuX,LuZ,ZhangP,ZhaoL,WessaleJL, 2008.Xanthine oxidase inhibition with febuxostat attenuates systolic overloadinduced left ventricular hypertrophy and dysfunction in mice,J Card Fail 14 746 -53
RekhrajS,GandySJ,SzwejkowskiBR,NadirMA,NomanA,HoustonJG, 2013.High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease,J Am Coll Cardiol 61 926 -32
SagorMA,TabassumN,PotolMA,AlamMA, 2015.Myocardial Damage in Isoproterenol Induced Aged Rats,Oxid Med Cell Longev 478039 -
2010.,Nucleosides Nucleotides Nucleic Acids 29 306 -13
Schillaci G., 2004.Pharmacogenomics of left ventricular hypertrophy reversal: beyond the "one size fits all" approach to antihypertensive therapy,J Hypertens 22 2273 -5
LindholmLH,IbsenH,DahlöfB,DevereuxRB,BeeversG,de FaireU, 2002.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol,Lancet 359 1004 -10
2014.associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patient's independent of blood pressure reduction - A LIFE review,J Electrocardiol 47 630 -5
2006.,Circulation 114 2508 -16
TakimotoE,KassDA, 2007.Role of oxidative stress in cardiac hypertrophy and remodelling,Hypertension 49 241 -8
2002.Role of oxidative stress in myocardial hypertrophy and failure,J Mol Cell Cardiol 34 379 -88
CingolaniHE,PlastinoJA,EscuderoEM,MangalB,BrownJ,PérezNG, 2006.The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study,J Card Fail 12 491 -8
SzwejkowskiBR,GandySJ,RekhrajS,HoustonJG,LangCC,MorrisAD, 2013.Allopurinol reduces left ventricular mass in patients with type 2 diabetes and left ventricular hypertrophy,J Am Coll Cardiol 62 2284 -93
HmarRC,KannangaraDR,RamasamySN,BaysariMT,WilliamsKM,DayRO, 2015.Understanding and improving the use of allopurinol in a teaching hospital,Intern Med J 45 383 -90